Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range159.11 | 161.41
52-Wk Range- | -
Last Close160.30
Mkt Cap (m)421,996.59
Dividend yield2.48
ISINUS4781601046
Volume7,630,813.00
Exchange VenueNYS

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Key Information
Price/Earning25.20
Price/Book6.54
Price/Sales5.30
P/CF19.83
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 24/08/2020
Annual Report
en 29/12/2019

Please refer to the below issuer website for further documents.

http://www.jnj.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)70,074.0071,890.0076,450.0081,581.0082,059.00-
Operating Income (m)18,065.0021,136.0018,714.0020,049.0020,080.00-
Net Income (m)15,409.0016,540.001,300.0015,297.0015,119.00-
Basic EPS5.566.040.485.705.72-
Avg. Diluted Shares Outstanding (m)2,812.902,788.902,745.302,728.702,684.30-
Balance Sheet
USD201520162017201820192020
Current Assets (m)60,210.0065,032.0043,088.0046,033.0045,274.00-
Non Current Assets (m)73,201.0076,176.00114,215.00106,921.00112,454.00-
Total Assets (m)133,411.00141,208.00157,303.00152,954.00157,728.00-
Current Liabilities (m)27,747.0026,287.0030,537.0031,230.0035,964.00-
Total Liabilities (m)------
Total Equity (m)71,150.0070,418.0060,160.0059,752.0059,471.00-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)19,279.0018,767.0021,056.0022,201.0023,416.00-
Capital Expenditure (m)-3,463.00-3,226.00-3,279.00-3,670.00-3,498.00-
Figures are quoted in USD unless stated otherwise
-
No change
$
160.30
Last Price